Report of Foreign Issuer (6-k)
December 11 2017 - 04:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 or 15d-16
UNDER
THE SECURITIES EXCHANGE ACT
of 1934
For the Month of December 2017
001-37521
(Commission File Number)
INTEC PHARMA LTD.
(Translation of registrant’s name into
English)
12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972) (2) 586-4657
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F
☒
Form
40-F
☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
EXPLANATORY
NOTE
On
December 11, 2017, Intec Pharma Ltd. (the “
Company
”) held its Annual General Meeting of Shareholders (the “
Meeting
”). At
the Meeting, the Company’s shareholders voted on the proposals detailed in the Company’s proxy statement for the Meeting
that was attached as Exhibit 99.1 to a Report of Foreign Private Issuer on Form 6-K that was furnished to the Securities and Exchange
Commission on November 6, 2017. Each matter voted upon was approved.
This
Form 6-K incorporated by reference into the Company’s registration statements on Form S-8 (Files No. 333-209700 and
No. 333-212801) and Form F-3 (Files No. 333-217189 and No. 333-218539).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INTEC PHARMA LTD.
|
|
|
|
By:
|
/s/ Nir Sassi
|
|
|
Name: Nir Sassi
|
|
|
Title: Chief Financial Officer
|
|
|
|
Date: December 11, 2017
|
|
|
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Mar 2023 to Mar 2024